- Lobbying
- Lobbying by Catalina Marketing
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Sean D'Arcy | Cnsl to Rep Pease, 1992 |
Vic Fazio | Mbr of Cong, 1979-98 |
David Carlin | Asst sec for Cong rels, USDA, 1995-98 |
Jayne Fitzgerald | Tax cnsl, H Ways & Means Comm, 1980-85 and 1992-95 |
Rob Leonard | Chief cnsl & staff dir, H Ways & Means Comm 1987-93 |
Kelly Maxwell | Staff asst/intrn, then leg asst, then spec asst, then leg dir for Rep Borski, Jan 98-Jan 03 |
Jeff McMillen | Staff dir, H Ways & Means Subcomm on Sel Rev Measures, Mar 01-Mar 04; staff, H Ways & Means Subcom on Oversight, /Jun 98-Mar 01 |
Josh Tzuker | Leg dir for Rep Dingell May 03-Aug 07; leg dir for Rep Matheson, Jan 01-May 03 |
J. David Carlin | n/a |
Gary A. Heimberg | n/a |
Jorge Lopez | n/a |
LAWRENCE A. (LADD) WILEY | n/a |
Jamie Tucker | n/a |
Joel Jankowsky | n/a |
Barney Skladany | n/a |
Ladd Wiley | n/a |
Kelly Cleary | n/a |
Travers Garvin | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Registration
Termination
Q2 Report
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS),
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Natl Institutes of Health (NIH)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate